School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Michael Lowe

  • Department of Surgery
    Associate Professor
  • mlowe3@emory.edu
Head shot of Michael Lowe

Overview

Dr. Lowe received his MD and graduated cum laude from Georgetown University School of Medicine. He served as administrative chief resident during the final year of his general surgery residency at the Emory Department of Surgery. He joined the Emory faculty after completing a fellowship in complex general surgical oncology at Memorial Sloan Kettering Cancer Center. Dr. Lowe received several awards during his training years, including the Young Investigator Award of the American Society of Transplant Surgeons in 2011 and 2012.

His clinical practice and research interests focus on cutaneous malignancies, particularly melanoma and Merkel cell carcinoma, and he is known for building a cutaneous malignancy program at Emory Saint Joseph's Hospital. Watch Dr. Lowe discuss aspects of treating melanoma in these educational videos produced by the Winship Cancer Institute: treating a recurrence of melanoma, using surgery to treat melanoma, and the role of the sentinel lymph node in melanoma.

In 2018, Dr. Lowe received the Society of Surgical Oncology's (SSO) Young Investigator Award for his study, "Evaluation of FcyRIIB as a Novel T cell Inhibitor in Cutaneous Melanoma." The study is investigating new pathways to enhance the immune system's response to melanoma, defining the role of the Fc receptor FcyRIIB in promoting exhaustion in T cell responses to tumor growth, and examining the benefits of blocking FcyRIIB's ability to alter T cell responses.

Academic Appointment

  • Associate Professor, Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine

Education

Degrees

  • MD from Georgetown University
  • MA from Georgetown University

Research

Publications

  • The Landmark Series: Melanoma and Adjuvant Therapy.
    Ann Surg Oncol Volume: 32 Page(s): 3212 - 3215
    05/01/2025 Authors: Lowe MC; Delman KA; Ollila DW
  • Combination radiation and PD-L1 enhance tumor control by stimulating CD8+PD-1+TCF-1+T cells in the tumor-draining lymph node.
    Nat Commun Volume: 16 Page(s): 3522
    04/14/2025 Authors: Shen Y; Connolly E; Aiello M; Zhou C; Chappa P; Song H; Tippitak P; Clark T; Cardenas M; Prokhnevska N
  • An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma.
    Ann Surg Oncol
    04/07/2025 Authors: Zager JS; Orloff M; Ferrucci PF; Choi J; Eschelman DJ; Glazer ES; Ejaz A; Howard JH; Richtig E; Ochsenreither S
  • The association of azole antifungals with overall survival in patients with non-small cell lung cancer receiving immune checkpoint inhibitors.
    Oncologist Volume: 30
    02/06/2025 Authors: Sebastian NT; Stokes WA; Behera M; Jiang R; Gutman DA; Huang Z; Burns A; Sukhatme V; Lowe MC; Ramalingam SS
  • Correction: Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study.
    Ann Surg Oncol Volume: 31 Page(s): 8262 - 8263
    11/01/2024 Authors: Zager JS; Orloff M; Ferrucci PF; Choi J; Eschelman DJ; Glazer ES; Ejaz A; Howard JH; Richtig E; Ochsenreither S
  • ASO Visual Abstract: Efficacy and Safety of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter, Phase 3 Study.
    Ann Surg Oncol Volume: 31 Page(s): 5220 - 5221
    08/01/2024 Authors: Zager JS; Orloff M; Ferrucci PF; Choi J; Eschelman DJ; Glazer ES; Ejaz A; Howard JH; Richtig E; Ochsenreither S
  • Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study.
    Ann Surg Oncol Volume: 31 Page(s): 5340 - 5351
    08/01/2024 Authors: Zager JS; Orloff M; Ferrucci PF; Choi J; Eschelman DJ; Glazer ES; Ejaz A; Howard JH; Richtig E; Ochsenreither S
  • Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis.
    J Immunother Cancer Volume: 12
    03/26/2024 Authors: Patel JS; Woo Y; Draper A; Jansen CS; Carlisle JW; Innominato PF; Lvi FA; Dhabaan L; Master VA; Bilen MA
  • Radiation and anti-PD-L1 synergize by stimulating a stem-like T cell population in the tumor-draining lymph node.
    Res Sq
    03/06/2024 Authors: Shen Y; Connolly E; Aiello M; Zhou C; Chappa P; Song H; Tippitak P; Clark T; Cardenas M; Prokhnevska N
  • Metastasectomy in Stage IV Melanoma: How and When Should We Employ It?
    Ann Surg Oncol Volume: 30 Page(s): 5312 - 5313
    09/01/2023 Authors: Faries MB; Lowe M
  • FcRIIB expressed on CD8+ T cells limits responsiveness to PD-1 checkpoint inhibition in cancer.
    Sci Transl Med Volume: 15 Page(s): eadd1868
    08/23/2023 Authors: Bennion KB; Tariq M; Wyatt MM; Duneton C; Baecher KM; Paulos CM; Kudchadkar RR; Lowe MC; Ford ML
  • International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers.
    Ann Surg Volume: 277 Page(s): e1106 - e1115
    05/01/2023 Authors: Broman KK; Hughes TM; Bredbeck BC; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF
  • The Association of Improved Overall Survival with NSAIDs in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.
    Clin Lung Cancer Volume: 24 Page(s): 287 - 294
    05/01/2023 Authors: Sebastian NT; Stokes WA; Behera M; Jiang R; Gutman DA; Huang Z; Burns A; Sukhatme V; Lowe MC; Ramalingam SS
  • HIV-1 DNA and Immune Activation Levels Differ for Long-Lived T-Cells in Lymph Nodes, Compared with Peripheral Blood, during Antiretroviral Therapy.
    J Virol Volume: 97 Page(s): e0167022
    04/27/2023 Authors: Mallarino-Haeger C; Pino M; Viox EG; Pagliuzza A; King CT; Nguyen K; Harper JL; Aldrete SDM; Cervasi B; Delman KA
  • Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
    N Engl J Med Volume: 388 Page(s): 813 - 823
    03/02/2023 Authors: Patel SP; Othus M; Chen Y; Wright GP; Yost KJ; Hyngstrom JR; Hu-Lieskovan S; Lao CD; Fecher LA; Truong T-G
  • Surgical Outcomes of SWOG1801: Neoadjuvant/adjuvant Versus Adjuvant Pembrolizumab for Resectable Stage III-IV Melanoma
    Volume: 30 Page(s): S49 - S49
    03/01/2023 Authors: Lowe MC; Hyngstrom JR; Wright GP; Othus M; Sharon E; Kirkwood JM; Ribas A; Patel SP; Sondak VK
  • A Multi-Institution Observational Analysis of the Theory of the Immunization Effect in Patients with Multiple Primary Melanomas
    Volume: 30 Page(s): S71 - S71
    03/01/2023 Authors: Zaladonis AG; Beasley GM; Broman KK; Correya T; Rhodin KE; Vandenberg J; Gabriel EM; Hieken TJ; Thompson J; Scolyer R
  • Patterns of recurrence and prognosis in pathologic stage I and II Merkel cell carcinoma: A multicenter, retrospective cohort analysis.
    J Am Acad Dermatol Volume: 88 Page(s): 251 - 253
    01/01/2023 Authors: Tieniber AD; Shannon AB; Carr MJ; Sun J; Landa K; Baecher KM; Lynch K; Bartels HG; Panchaud R; Lowe MC
  • Impact of concomitant fibrates on immunotherapy outcomes for advanced non-small cell lung cancer.
    Cancer Med Volume: 12 Page(s): 358 - 367
    01/01/2023 Authors: Stokes WA; Behera M; Jiang R; Gutman DA; Huang Z; Burns A; Sebastian NT; Sukhatme V; Lowe MC; Ramalingam SS
  • Regional control after precision lymph node dissection for clinically evident melanoma metastasis.
    J Surg Oncol Volume: 127 Page(s): 140 - 147
    01/01/2023 Authors: Lynch KT; Hu Y; Farrow NE; Song Y; Meneveau MO; Kwak M; Lowe MC; Bartlett EK; Beasley GM; Karakousis GC
  • A Prospective Multi-Institutional Trial Examining the Feasibility, Accuracy and Learning Curve of Fluorescence Imaging for Sentinel Node Localization in Melanoma
    Volume: 235 Page(s): S79 - S79
    11/01/2022 Authors: Pameijer CRJ; Neves RI; Nitzkorski JR; Lowe MC
  • ASO Visual Abstract: An Internally Validated Prognostic Risk Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma.
    Ann Surg Oncol Volume: 29 Page(s): 7045 - 7046
    10/01/2022 Authors: Shannon AB; Straker RJ; Carr MJ; Sun J; Landa K; Baecher K; Lynch K; Bartels HG; Panchaud R; Keele LJ
  • An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma.
    Ann Surg Oncol Volume: 29 Page(s): 7033 - 7044
    10/01/2022 Authors: Shannon AB; Straker RJ; Carr MJ; Sun J; Landa K; Baecher K; Lynch K; Bartels HG; Panchaud R; Keele LJ
  • Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II).
    Ann Surg Oncol Volume: 29 Page(s): 5910 - 5920
    09/01/2022 Authors: Jakub JW; Lowe M; Howard JH; Farma JM; Sarnaik A; Tuttle T; Neuman HB; Ariyan CE; Uppal A; Trocha S
  • Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection.
    J Immunother Cancer Volume: 10
    08/01/2022 Authors: Eroglu Z; Broman KK; Thompson JF; Nijhuis A; Hieken TJ; Kottschade L; Farma JM; Hotz M; Deneve J; Fleming M
  • Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).
    Ann Surg Oncol Volume: 29 Page(s): 5241 - 5242
    08/01/2022 Authors: van Akkooi ACJ; Hieken TJ; Burton EM; Ariyan C; Ascierto PA; Asero SVMA; Blank CU; Block MS; Boland GM; Caraco C
  • Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).
    Ann Surg Oncol Volume: 29 Page(s): 3694 - 3708
    06/01/2022 Authors: van Akkooi ACJ; Hieken TJ; Burton EM; Ariyan C; Ascierto PA; Asero SVMA; Blank CU; Block MS; Boland GM; Caraco C
  • Neoadjuvant Intralesional Therapy for High Risk Stage II Melanoma
    Volume: 29 Page(s): 534 - 534
    05/01/2022 Authors: Lowe MC; Ahmad MU; Sun B; Gholami S; Maverakis E; Kirane AR
  • Neuroendocrine Gene Expression in Primary Melanoma Tumors of Obese and Normal-Weight Patients
    Volume: 29 Page(s): 464 - 464
    05/01/2022 Authors: Harrell CS; Bhasin M; Baecher KM; Dwivedi B; Delman KA; Lowe MC
  • A Phase III, Multicenter, Randomized Controlled Trial Investigating 1-cm Versus 2-cm Surgical Excision Margins for Stage II Primary Cutaneous Melanoma (MelMarT-II).
    Ann Surg Oncol
    04/22/2022 Authors: Rossi AJ; Verbus EA; Faries MB; Moncrieff M; Henderson M; Hernandez JM; Lowe MC
  • Do Oncologic Outcomes From Head and Neck Versus Truncal and Extremity Melanoma Differ? A Single-Institution Single-Subspecialty Experience.
    Am Surg Volume: 88 Page(s): 480 - 488
    03/01/2022 Authors: Baecher KM; Turgeon MK; Medin CR; Mahendran G; Flakes TM; Delman KA; Lowe MC
  • ASO Visual Abstract: Talimogene Laherparepvec (T-VEC) for Treatment of Advanced Locoregional Melanoma after Failure of Immunotherapy: An International Multi-institutional Experience.
    Ann Surg Oncol Volume: 29 Page(s): 804 - 805
    02/01/2022 Authors: Carr MJ; Sun J; DePalo D; Rothermel LD; Song Y; Straker RJ; Baecher K; Louie RJ; Stahlie EHA; Wright GP
  • Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience.
    Volume: 29 Page(s): 791 - 801
    02/01/2022 Authors: Carr MJ; Sun J; DePalo D; Rothermel LD; Song Y; Straker RJ; Baecher K; Louie RJ; Stahlie EHA; Wright GP
  • Ford Versus Ferrari: Novel Technologies in the Setting of a Reliable Standard.
    Ann Surg Oncol Volume: 29 Page(s): 758 - 759
    02/01/2022 Authors: Delman KA; Mason MC; Lowe MC
  • Correction to: The Devil's in the Details: Discrepancy Between Biopsy Thickness and Final Pathology in Acral Melanoma.
    Ann Surg Oncol Volume: 28 Page(s): 876
    12/01/2021 Authors: Lee AY; Friedman EB; Sun J; Potdar A; Daou H; Farrow NE; Farley CR; Vetto JT; Han D; Tariq M
  • In Search of a More Accurate Nodal Staging System for Melanoma: Should We Sacrifice Simplicity?
    JAMA Surg Volume: 156 Page(s): e214306
    11/01/2021 Authors: Baecher K; Delman K; Lowe M
  • Predictors of False Negative Sentinel Lymph Node Biopsy in Clinically Localized Merkel Cell Carcinoma.
    Volume: 28 Page(s): 6995 - 7003
    11/01/2021 Authors: Straker RJ; Carr MJ; Sinnamon AJ; Shannon AB; Sun J; Landa K; Baecher KM; Wood C; Lynch K; Bartels HG
  • ASO Author Reflections: Cutaneous Melanoma as Model System for the Obesity Paradox in Cancer.
    Ann Surg Oncol Volume: 28 Page(s): 6152 - 6153
    10/01/2021 Authors: Harrell Shreckengost C; Lowe MC
  • The Impact of Obesity on Surgically Treated Locoregional Melanoma.
    Ann Surg Oncol Volume: 28 Page(s): 6140 - 6151
    10/01/2021 Authors: Harrell Shreckengost CS; Tariq M; Farley CR; Zhang C; Delman KA; Kudchadkar RR; Lowe MC
  • Data extraction accuracy in stage III melanoma from a clinical data warehouse
    Volume: 85 Page(s): AB90 - AB90
    09/01/2021 Authors: Francois S; Adler CH; Flowers NI; Little KB; Lowe MC; Chen SC; Yeung H
  • Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART.
    PLoS Pathog Volume: 17 Page(s): e1009825
    08/01/2021 Authors: Pino M; Pereira Ribeiro S; Pagliuzza A; Ghneim K; Khan A; Ryan E; Harper JL; King CT; Welbourn S; Micci L
  • Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
    Cancer Volume: 127 Page(s): 2251 - 2261
    07/01/2021 Authors: Broman KK; Hughes T; Dossett L; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF
  • Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis.
    J Am Coll Surg Volume: 232 Page(s): 424 - 431
    04/01/2021 Authors: Broman KK; Hughes TM; Dossett LA; Sun J; Carr MJ; Kirichenko DA; Sharma A; Bartlett EK; Nijhuis AA; Thompson JF
  • The evolving landscape of immunotherapy in solid tumors.
    J Surg Oncol Volume: 123 Page(s): 798 - 806
    03/01/2021 Authors: Keilson JM; Knochelmann HM; Paulos CM; Kudchadkar RR; Lowe MC
  • FcRIIB is a T cell checkpoint in antitumor immunity.
    JCI Insight Volume: 6
    02/22/2021 Authors: Farley CR; Morris AB; Tariq M; Bennion KB; Potdar S; Kudchadkar R; Lowe MC; Ford ML
  • Safety of Talimogene Laherparepvec in the Geriatric Melanoma Patient: A Multi-Institutional Experience
    Volume: 28 Page(s): S107 - S108
    02/01/2021 Authors: Johnson J; Louie RJ; Carr MJ; Baecher K; Collichio F; Lowe MC; Sarnaik AA; Delman KA; Zager JS; Ollila DW
  • A Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma
    Volume: 28 Page(s): S29 - S29
    02/01/2021 Authors: Shannon AB; Carr MJ; Straker RJ; Sun J; Landa K; Baecher K; Lynch K; Bartels HG; Panchaud R; Lowe MC
  • Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis.
    Cancer Control Volume: 28 Page(s): 10732748211053567
    01/01/2021 Authors: Kolla AM; Vitiello GA; Friedman EB; Sun J; Potdar A; Daou H; Farrow NE; Farley CR; Vetto JT; Han D
  • Oncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparisonof the Procedure and Outcomes Between the United States and Australia.
    Ann Surg Oncol Volume: 27 Page(s): 5107 - 5118
    12/01/2020 Authors: Carr MJ; Sun J; Kroon HM; Miura JT; Beasley GM; Farrow NE; Mosca PJ; Lowe MC; Farley CR; Kim Y
  • Correction to: Merkel Cell Carcinoma Outcomes: Does AJCC8 Underestimate Survival?
    Ann Surg Oncol Volume: 27 Page(s): 983
    12/01/2020 Authors: Farley CR; Perez MC; Soelling SJ; Delman KA; Harit A; Wuthrick EJ; Messina JL; Sondak VK; Zager JS; Lowe MC
  • The Devil's in the Details: Discrepancy Between Biopsy Thickness and Final Pathology in Acral Melanoma.
    Ann Surg Oncol Volume: 27 Page(s): 5259 - 5266
    12/01/2020 Authors: Lee AY; Friedman EB; Sun J; Potdar A; Daou H; Farrow NE; Farley CR; Vetto JT; Han D; Tariq M
  • Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre study.
    Volume: 46 Page(s): 2140 - 2146
    11/01/2020 Authors: Kenyon-Smith TJ; Kroon HM; Miura JT; Teras J; Beasley GM; Mullen D; Farrow NE; Mosca PJ; Lowe MC; Farley CR
  • Reducing injury response to surgery with repurposed drugs: An evolving approach to prevention of cancer metastases.
    Cancer Volume: 126 Page(s): 3916 - 3918
    09/01/2020 Authors: Lowe M; Sukhatme VV; Sukhatme VP
  • Management of Melanoma Patients with Positive Nodes.
    Volume: 54 Page(s): 191 - 204
    09/01/2020 Authors: Lee RM; Delman KA; Lowe MC
  • Neoadjuvant Therapy for Melanoma.
    Surg Oncol Clin N Am Volume: 29 Page(s): 445 - 453
    07/01/2020 Authors: Lowe MC; Kudchadkar RR
  • The (R)evolution of Melanoma Care.
    Surg Oncol Clin N Am Volume: 29 Page(s): xv - xvi
    07/01/2020 Authors: Delman KA; Lowe MC
  • Merkel Cell Carcinoma Outcomes: Does AJCC8 Underestimate Survival?
    Ann Surg Oncol Volume: 27 Page(s): 1978 - 1985
    06/01/2020 Authors: Farley CR; Perez MC; Soelling SJ; Delman KA; Harit A; Wuthrick EJ; Messina JL; Sondak VK; Zager JS; Lowe MC
  • S1801: A randomized phase II trial of adjuvant versus neoadjuvant pembrolizumab (PEM) for melanoma.
    Volume: 38
    05/20/2020 Authors: Patel SP; Othus M; Moon J; Tetzlaff MT; Buchbinder EI; Sondak VK; Lowe MC; Campos D; Sharon E; Korde LA
  • Integrated biomarker study of neoadjuvant pepinemab and nivolumab in patients with resectable metastatic melanoma.
    Volume: 38
    05/20/2020 Authors: Lowe MC; Olson B; Martinez A; Hammons J; Delman KA; Yushak ML; Allor M; Reilly CA; Mallow CL; Evans EE
  • International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients.
    Ann Surg Oncol Volume: 27 Page(s): 1420 - 1429
    05/01/2020 Authors: Teras J; Kroon HM; Miura JT; Kenyon-Smith T; Beasley GM; Mullen D; Farrow NE; Mosca PJ; Lowe MC; Farley CR
  • Metastatic melanoma.
    CA Cancer J Clin Volume: 70 Page(s): 78 - 85
    03/01/2020 Authors: Kudchadkar RR; Lowe MC; Khan MK; McBrien SM
  • Active Surveillance of Melanoma Patients with Sentinel Node Metastasis: An International Multi-Institution Evaluation of Post-MSLT-2 Adoption and Early Outcomes
    Volume: 27 Page(s): S30 - S31
    02/01/2020 Authors: Broman K; Hughes TM; Dossett LA; Sun J; Kirichenko D; Carr MJ; Hieken TJ; Kottschade L; Downs J; Gyorki DE
  • Oncologic Outcomes After Isolated Limb Infusion (ILI) for Advanced Melanoma: An International Comparison between the US and Australia
    Volume: 27 Page(s): S35 - S35
    02/01/2020 Authors: Sun J; Kroon HM; Miura JT; Beasley GM; Farrow NE; Mosca P; Lowe MC; Farley CR; Kim Y; Naqvi SM
  • Recurrence Patterns After Negative Sentinel Lymph Node Biopsy for Melanoma
    Volume: 27 Page(s): S197 - S197
    02/01/2020 Authors: Soelling S; Delman KA; Lowe MC
  • Surgical Considerations and Systemic Therapy of Melanoma.
    Surg Clin North Am Volume: 100 Page(s): 141 - 159
    02/01/2020 Authors: Gamboa AC; Lowe M; Yushak ML; Delman KA
  • Triple therapy with intralesional 5-fluorouracil, chemowraps, and acitretin: A well-tolerated option for treatment of widespread cutaneous squamous cell carcinomas on the legs.
    JAAD Case Rep Volume: 5 Page(s): 1051 - 1054
    12/01/2019 Authors: Manalo IF; Lowe MC; Nelson KC; Chen SC
  • A Call to Arms: Surgeons Must Play an Important and Early Role in the Management of Patients with Advanced Melanoma.
    Ann Surg Oncol Volume: 26 Page(s): 4180 - 4181
    12/01/2019 Authors: Lowe MC; Delman KA
  • Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis.
    Ann Surg Oncol Volume: 26 Page(s): 2486 - 2494
    08/01/2019 Authors: Miura JT; Kroon HM; Beasley GM; Mullen D; Farrow NE; Mosca PJ; Lowe MC; Farley CR; Kim Y; Naqvi SMH
  • Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium.
    Lancet Oncol Volume: 20 Page(s): e378 - e389
    07/01/2019 Authors: Amaria RN; Menzies AM; Burton EM; Scolyer RA; Tetzlaff MT; Antdbacka R; Ariyan C; Bassett R; Carter B; Daud A
  • Management of intussusception in patients with melanoma.
    J Surg Oncol Volume: 119 Page(s): 897 - 902
    06/01/2019 Authors: Perez MC; Sun J; Farley C; Han D; Sun AH; Narayan D; Lowe M; Delman KA; Messina JL; Gonzalez RJ
  • Pilot integrated biomarker study of VX15/2503 in combination with ipilimumab and/or nivolumab in patients with resectable metastatic melanoma.
    Volume: 37
    05/20/2019 Authors: Lowe MC; Lesinski GB; Delman KA; Yushak ML; Evans EE; Fisher TL; Kudchadkar RR
  • Real-World Outcomes of Talimogene Laherparepvec Therapy: A Multi-Institutional Experience.
    J Am Coll Surg Volume: 228 Page(s): 644 - 649
    04/01/2019 Authors: Louie RJ; Perez MC; Jajja MR; Sun J; Collichio F; Delman KA; Lowe M; Sarnaik AA; Zager JS; Ollila DW
  • Neoadjuvant therapy of locally/regionally advanced melanoma.
    Ther Adv Med Oncol Volume: 11 Page(s): 1758835919866959
    01/01/2019 Authors: Khunger A; Buchwald ZS; Lowe M; Khan MK; Delman KA; Tarhini AA
  • Neoadjuvant Treatments for Advanced Resectable Melanoma.
    J Surg Oncol Volume: 119 Page(s): 216 - 221
    01/01/2019 Authors: Liu JY; Lowe M
  • ASO Author Reflections: Optimizing the Outcomes for Patients: The Evolution of the Management of Regional Disease in Patients with Melanoma.
    Ann Surg Oncol Volume: 25 Page(s): 908 - 909
    12/01/2018 Authors: Lowe MC; Farley CR; Delman KA
  • Recurrence Patterns after Primary Excision of Invasive Melanoma with Melanoma in situ at the Margin.
    Am Surg Volume: 84 Page(s): 1319 - 1325
    08/01/2018 Authors: Oh G; Farley CR; Lopez-Aguiar AG; Russell MC; Delman KA; Lowe MC
  • Phase II trial of pembrolizumab (MK-3475) in metastatic cutaneous squamous cell carcinoma (cSCC)
    Volume: 36
    05/20/2018 Authors: Kudchadkar RR; Yushak ML; Lawson DH; Delman KA; Lowe MC; Goings M; McBrien S; Mckellar M; Sieja K; Maynard N
  • Morbidity and Outcomes Following Axillary Lymphadenectomy for Melanoma: Weighing the Risk of Surgery in the Era of MSLT-II.
    Ann Surg Oncol Volume: 25 Page(s): 465 - 470
    02/01/2018 Authors: Postlewait LM; Farley CR; Seamens AM; Le N; Rizzo M; Russell MC; Lowe MC; Delman KA
  • Belatacept-Resistant Rejection Is Associated With CD28+ Memory CD8 T Cells.
    Am J Transplant Volume: 17 Page(s): 2285 - 2299
    09/01/2017 Authors: Mathews DV; Wakwe WC; Kim SC; Lowe MC; Breeden C; Roberts ME; Farris AB; Strobert EA; Jenkins JB; Larsen CP
  • Revisiting the Strait of Messina: The Balance Between Optimal Oncologic Outcomes and Complications From Surgery.
    Ann Surg Oncol Volume: 24 Page(s): 302 - 304
    02/01/2017 Authors: Delman KA; Lowe MC
  • Anatomy of Hepatic Resectional Surgery.
    Surg Clin North Am Volume: 96 Page(s): 183 - 195
    04/01/2016 Authors: Lowe MC; D'Angelica MI
  • Evaluation of the effects of neoadjuvant therapy on stage specific outcome estimates in patients with completely resected gastric cancer.
    Volume: 34
    02/01/2016 Authors: Lowe MC; Chou JF; Capanu M; Coit DG
  • Overall Survival After Surgical Resection of Diffuse Type Gastric Adenocarcinoma is Equivalent in Caucasians and Asians
    Volume: 23 Page(s): S169 - S169
    02/01/2016 Authors: Lowe MC; Son S; Strong VE; Coit DG; Yoon S; Park D
  • Dual islet transplantation modeling of the instant blood-mediated inflammatory reaction.
    Am J Transplant Volume: 15 Page(s): 1241 - 1252
    05/01/2015 Authors: Martin BM; Samy KP; Lowe MC; Thompson PW; Cano J; Farris AB; Song M; Dove CR; Leopardi FV; Strobert EA
  • Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma.
    Am J Clin Oncol Volume: 37 Page(s): 580 - 584
    12/01/2014 Authors: Marcus DM; Lowe M; Khan MK; Lawson DH; Crocker IR; Shelton JW; Melton A; Maynard N; Delman KA; Carlson GW
  • Belatacept and sirolimus prolong nonhuman primate islet allograft survival: adverse consequences of concomitant alefacept therapy.
    Am J Transplant Volume: 13 Page(s): 312 - 319
    02/01/2013 Authors: Lowe MC; Badell IR; Turner AP; Thompson PW; Leopardi FV; Strobert EA; Larsen CP; Kirk AD
  • A novel monoclonal antibody to CD40 prolongs islet allograft survival.
    Am J Transplant Volume: 12 Page(s): 2079 - 2087
    08/01/2012 Authors: Lowe M; Badell IR; Thompson P; Martin B; Leopardi F; Strobert E; Price AA; Abdulkerim HS; Wang R; Iwakoshi NN
  • Alternative immunomodulatory strategies for xenotransplantation: CD40/154 pathway-sparing regimens promote xenograft survival.
    Am J Transplant Volume: 12 Page(s): 1765 - 1775
    07/01/2012 Authors: Thompson P; Badell IR; Lowe M; Turner A; Cano J; Avila J; Azimzadeh A; Cheng X; Pierson RN; Johnson B
  • A Novel Non-Depleting Monoclonal Antibody to CD40 Prolongs Islet Allograft Survival
    AMERICAN JOURNAL OF TRANSPLANTATION Volume: 12 Page(s): 35 - 35
    05/01/2012 Authors: Lowe MC; Badell IR; Thompson P; Martin B; Strobert E; Price AA; Abdulkerim HS; Wang R; Iwakoshi NN; Adams AB
  • Belatacept and Sirolimus Prolong Islet Allograft Survival in Nonhuman Primates
    AMERICAN JOURNAL OF TRANSPLANTATION Volume: 12 Page(s): 479 - 479
    05/01/2012 Authors: Lowe MC; Badell IR; Turner A; Thompson P; Martin B; Leopardi F; Strobert E; Larsen CP; Kirk AD
  • Management of papillary breast lesions diagnosed on core-needle biopsy: clinical pathologic and radiologic analysis of 276 cases with surgical follow-up.
    J Am Coll Surg Volume: 214 Page(s): 280 - 287
    03/01/2012 Authors: Rizzo M; Linebarger J; Lowe MC; Pan L; Gabram SGA; Vasquez L; Cohen MA; Mosunjac M
  • Islet xenotransplantation using gal-deficient neonatal donors improves engraftment and function.
    Am J Transplant Volume: 11 Page(s): 2593 - 2602
    12/01/2011 Authors: Thompson P; Badell IR; Lowe M; Cano J; Song M; Leopardi F; Avila J; Ruhil R; Strobert E; Korbutt G
  • The impact of shave biopsy on the management of patients with thin melanomas.
    Am Surg Volume: 77 Page(s): 1050 - 1053
    08/01/2011 Authors: Lowe M; Hill N; Page A; Chen S; Delman KA
  • The impact of country and culture on end-of-life care for injured patients: results from an international survey.
    J Trauma Volume: 69 Page(s): 1323 - 1333
    12/01/2010 Authors: Ball CG; Navsaria P; Kirkpatrick AW; Vercler C; Dixon E; Zink J; Laupland KB; Lowe M; Salomone JP; Dente CJ
  • Ipilimumab for advanced melanoma: let's not throw caution to the winds.
    Oncology (Williston Park) Volume: 24 Page(s): 1296 - 1299
    12/01/2010 Authors: Lowe M; Delman KA
  • The role of radio-surgery in patients with metastatic melanoma to the brain
    Volume: 28
    05/20/2010 Authors: Lowe MC; Cavitt A; Shelton J; Crocker IR; Pan L; Lawson DH; Carlson GW; Delman KA; Rizzo M
  • Deep margin involvement after shave biopsy-for melanoma and requirement for sentinel lymph node biopsy (SLAB)
    JOURNAL OF CLINICAL ONCOLOGY Volume: 28
    05/20/2010 Authors: Page A; Lowe MC; Hill N; Murray DR; Carlson GW; Bonaccorsi P; Chen S; Delman KA
  • Important Prognostic Factors in Adenocarcinoma of the Ampulla of Vater DISCUSSION
    AMERICAN SURGEON Volume: 75 Page(s): 761 - 761
    09/01/2009 Authors: Nauta RJ; Reiling R; Lowe MC
  • Important prognostic factors in adenocarcinoma of the ampulla of Vater.
    Am Surg Volume: 75 Page(s): 754 - 760
    09/01/2009 Authors: Lowe MC; Coban I; Adsay NV; Sarmiento JM; Chu CK; Staley CA; Galloway JR; Kooby DA
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2024 Emory University
  • Privacy Policy
  • Emergency Information